.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2015 for a whopping ...
.On the heels of a phase 3 win that fell short to make an impression on investors, Ironwood Pharmace...
.Do not stop Monte Rosa Rehabs currently. The Boston-based biotech is enjoying after signing a deal ...
.Accept to this week's Chutes & Ladders, our summary of significant leadership hirings, shootings...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the positi...
.AbbVie has returned to the resource of its antipsychotic goliath Vraylar seeking yet another runawa...
.GenSight Biologics is weeks out of losing funds. Again. The biotech only possesses sufficient cash ...
.Monopar Therapeutics is recuperating a medicine from the scrap heap of AstraZeneca's uncommon disea...
.With brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of analysts e...
.After developing a gene treatment collaboration along with Dyno Rehabs in 2020, Roche is actually b...